HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 170 filers reported holding HAEMONETICS CORP in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,137 | +2.5% | 12,698 | -2.5% | 0.00% | 0.0% |
| Q2 2023 | $1,109 | +0.6% | 13,021 | -2.2% | 0.00% | 0.0% |
| Q1 2023 | $1,102 | +4.0% | 13,314 | -1.2% | 0.00% | 0.0% |
| Q4 2022 | $1,060 | -99.9% | 13,480 | -0.8% | 0.00% | 0.0% |
| Q3 2022 | $1,005,000 | +15.0% | 13,582 | +1.3% | 0.00% | +50.0% |
| Q2 2022 | $874,000 | +3.6% | 13,409 | +0.4% | 0.00% | 0.0% |
| Q1 2022 | $844,000 | -56.0% | 13,356 | -63.1% | 0.00% | -50.0% |
| Q4 2021 | $1,920,000 | +51.5% | 36,203 | +101.7% | 0.00% | +33.3% |
| Q3 2021 | $1,267,000 | +4.7% | 17,952 | -1.1% | 0.00% | +50.0% |
| Q2 2021 | $1,210,000 | -84.8% | 18,157 | -74.6% | 0.00% | -88.2% |
| Q1 2021 | $7,946,000 | +60.0% | 71,579 | +71.1% | 0.02% | +54.5% |
| Q4 2020 | $4,966,000 | -31.2% | 41,827 | -49.4% | 0.01% | -42.1% |
| Q3 2020 | $7,213,000 | +478.4% | 82,675 | +494.0% | 0.02% | +375.0% |
| Q2 2020 | $1,247,000 | -5.5% | 13,919 | +5.1% | 0.00% | -20.0% |
| Q1 2020 | $1,320,000 | -13.3% | 13,243 | 0.0% | 0.01% | +25.0% |
| Q4 2019 | $1,522,000 | -8.5% | 13,243 | +0.5% | 0.00% | -20.0% |
| Q3 2019 | $1,663,000 | +2.0% | 13,182 | -2.7% | 0.01% | 0.0% |
| Q2 2019 | $1,631,000 | +39.3% | 13,553 | +1.3% | 0.01% | +25.0% |
| Q1 2019 | $1,171,000 | -10.9% | 13,381 | +1.9% | 0.00% | -20.0% |
| Q4 2018 | $1,314,000 | -8.9% | 13,134 | +4.3% | 0.01% | 0.0% |
| Q3 2018 | $1,443,000 | +35.2% | 12,591 | +5.9% | 0.01% | +66.7% |
| Q2 2018 | $1,067,000 | -59.5% | 11,895 | -67.0% | 0.00% | -66.7% |
| Q1 2018 | $2,635,000 | +39.2% | 36,013 | +10.5% | 0.01% | +50.0% |
| Q4 2017 | $1,893,000 | +32.0% | 32,593 | +2.0% | 0.01% | +20.0% |
| Q3 2017 | $1,434,000 | +14.4% | 31,950 | +0.6% | 0.01% | 0.0% |
| Q2 2017 | $1,254,000 | -80.7% | 31,760 | -80.2% | 0.01% | -82.1% |
| Q1 2017 | $6,506,000 | +482.5% | 160,360 | +477.2% | 0.03% | +460.0% |
| Q4 2016 | $1,117,000 | +18.2% | 27,780 | +6.5% | 0.01% | +25.0% |
| Q3 2016 | $945,000 | +31.6% | 26,090 | +5.4% | 0.00% | +33.3% |
| Q2 2016 | $718,000 | -77.0% | 24,760 | -72.3% | 0.00% | -80.0% |
| Q1 2016 | $3,123,000 | +344.9% | 89,270 | +310.2% | 0.02% | +400.0% |
| Q4 2015 | $702,000 | +3.2% | 21,760 | +3.4% | 0.00% | -25.0% |
| Q3 2015 | $680,000 | -18.2% | 21,050 | +4.7% | 0.00% | -20.0% |
| Q2 2015 | $831,000 | -2.6% | 20,100 | +5.8% | 0.01% | 0.0% |
| Q1 2015 | $853,000 | +21.2% | 19,000 | +1.1% | 0.01% | +25.0% |
| Q4 2014 | $704,000 | +7.5% | 18,800 | +0.3% | 0.00% | 0.0% |
| Q3 2014 | $655,000 | -2.5% | 18,750 | -1.6% | 0.00% | 0.0% |
| Q2 2014 | $672,000 | +9.1% | 19,050 | +0.8% | 0.00% | 0.0% |
| Q1 2014 | $616,000 | -22.2% | 18,900 | +0.5% | 0.00% | -20.0% |
| Q4 2013 | $792,000 | +6.2% | 18,800 | +0.5% | 0.01% | 0.0% |
| Q3 2013 | $746,000 | -3.5% | 18,700 | 0.0% | 0.01% | 0.0% |
| Q2 2013 | $773,000 | – | 18,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LGT CAPITAL PARTNERS LTD. | 1,216,059 | $64,500,000 | 1.72% |
| HEARTLAND ADVISORS INC | 406,192 | $21,544,000 | 1.26% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 200,000 | $10,608,000 | 1.22% |
| Aurora Investment Counsel | 32,149 | $1,705,000 | 1.01% |
| Endurant Capital Management LP | 73,914 | $3,920,000 | 0.95% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 135,000 | $7,160,000 | 0.82% |
| ARMISTICE CAPITAL, LLC | 872,000 | $46,251,000 | 0.76% |
| Summit Creek Advisors LLC | 131,357 | $6,967,000 | 0.70% |
| Dean Capital Management | 15,309 | $812,000 | 0.70% |
| Keene & Associates, Inc. | 11,720 | $622,000 | 0.54% |